Shares of HIMS experienced a dramatic drop today following the unexpected termination of its partnership with pharmaceutical giant Novo Nordisk. Investors interpreted negatively to the news, sending its stock price plummeting by nearly fifteen percent. The reason for the breakdown of the partnership remains unclear, but industry analysts speculate